BamSEC and AlphaSense Join Forces
Learn More

Syros Pharmaceuticals Inc.

NASDAQ: SYRS    
Share price (1/8/25): $0.21    
Market cap (1/8/25): $5.635 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 10-Q 35 pages Restated Certificate of Incorporation of Syros Pharmaceuticals, Inc
12/34/56
EX-3.1
from 10-Q 33 pages Restated Certificate of Incorporation of Syros Pharmaceuticals, Inc
12/34/56
EX-3.2
from 8-K 3 pages Certificate of Amendment of Restated Certificate of Incorporation of Syros Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Restated Certificate of Incorporation of Syros Pharmaceuticals, Inc
12/34/56
EX-3.2
from 10-Q 21 pages Second Amended and Restated By-Laws of Syros Pharmaceuticals, Inc
12/34/56
EX-3.1
from 10-Q 26 pages Restated Certificate of Incorporation of Syros Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 13 pages Syros Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Series a Convertible Preferred Stock
12/34/56
EX-3.2
from 8-K 28 pages Stockholders
12/34/56
EX-3.1
from 8-K 10 pages Restated Certificate of Incorporation of Syros Pharmaceuticals, Inc
12/34/56
EX-3.1
from S-1/A 33 pages Third Amended and Restated Certificate of Incorporation of Syros Pharmaceuticals, Inc
12/34/56
EX-3.4
from S-1 26 pages Stockholders
12/34/56
EX-3.3
from S-1 10 pages Restated Certificate of Incorporation of Syros Pharmaceuticals, Inc
12/34/56
EX-3.2
from S-1 15 pages By-Laws of Ls22, Inc
12/34/56
EX-3.1
from S-1 26 pages Third Amended and Restated Certificate of Incorporation of Syros Pharmaceuticals, Inc
12/34/56
EX-3.4
from DRS/A 26 pages Stockholders
12/34/56
EX-3.3
from DRS/A 10 pages Restated Certificate of Incorporation of Syros Pharmaceuticals, Inc
12/34/56
EX-3.2
from DRS 15 pages By-Laws of Ls22, Inc
12/34/56
EX-3.1
from DRS 26 pages Third Amended and Restated Certificate of Incorporation of Syros Pharmaceuticals, Inc
12/34/56